Cleared Traditional

MILLENIUM MICROKERATOME, MODEL IMD-001 (K992687) - FDA 510(k) Clearance

Class I Ophthalmic device.

K992687 · Industrial & Medical Design, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1999
Decision
45d
Days
Class 1
Risk

K992687 is an FDA 510(k) clearance for the MILLENIUM MICROKERATOME, MODEL IMD-001. Classified as Keratome, Battery-powered (product code HMY), Class I - General Controls.

Submitted by Industrial & Medical Design, Inc. (Los Angeles, US). The FDA issued a Cleared decision on September 24, 1999 after a review of 45 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4370 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Industrial & Medical Design, Inc. devices

Submission Details

510(k) Number K992687 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 10, 1999
Decision Date September 24, 1999
Days to Decision 45 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 110d · This submission: 45d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HMY Keratome, Battery-powered
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 886.4370
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.